草甘在Mg-Al分层双氧化物中的间位和其受控释放
Emanoel Hottes1, Gladson de Souza Machado1, Glauco Favilla Bauerfeldt1
1Instituto de Química, Universidade Federal Rural do Rio de Janeiro, CEP 23890-000 Seropédica, RJ, Brasil.
ACS omega
|February 23, 2026
概括
合成了多层双氧化物 (LDH) 来捕获草甘. --甘酸盐混合物材料显示成功的间隔,释放受pH和碳酸盐度的影响.
科学领域:
- 材料科学 材料科学 材料科学
- 环境化学环境化学
- 纳米技术纳米技术
背景情况:
- 层状双氧化物 (LDH) 是具有调节性质的多功能材料.
- 草甘是一种广泛使用的除草剂,对环境有影响.
- 开发有效的草甘修复方法至关重要.
研究的目的:
- 合成基于Mg-Al的分层双氧化物 (LDHs) 用于草甘间隔.
- 为了研究Mg-Al-甘酸盐混合物材料的结构特征和形成.
- 在不同条件下,评估草甘从合成的LDH中释放的动力学.
主要方法:
- 使用重建和共沉降方法合成Mg-Al-LDHs.
- 用于结构分析和结晶性评估的X射线衍射 (XRD).
- 固态核磁共振 (NMR) 和富里埃变换红外衰减总反射率 (FT-IR-ATR) 用于材料特性.
- 基于pH值的释放研究和动力模型.
- 对草甘释放的阳离子影响研究 (碳酸盐,酸盐,化物).
主要成果:
- 通过这两种方法成功合成了Mg-Al-甘酸盐混合物材料,共沉降产生了更好的结晶性.
- 有证据表明,垂直草甘的间隙与7.9 Å的膜间距.
- 核磁共振和FT-IR-ATR光谱证实了物质形成和草甘相互作用.
- 在pH10下观察到的最大草甘释放量 (~70%),遵循第一阶动力学.
- 碳酸盐离子显著影响了草甘的释放,度增加导致释放率更高,也受第一阶动力学的支配.
结论:
- Mg-Al-LDHs对于草甘间隔和潜在的补救是有效的.
- 草甘的释放可以通过pH控制,并且受到碳酸盐度的显著影响.
- 一级动力学在研究条件下控制草甘释放,为环境应用提供了洞察力.
更多相关视频
04:09Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
Published on: December 13, 2024
1.4K
07:07Controlled-release of Chlorine Dioxide in a Perforated Packaging System to Extend the Storage Life and Improve the Safety of Grape Tomatoes
Published on: April 7, 2017
11.6K
相关概念视频
01:11Oral Drug Delivery Systems: Delayed-Release Systems
44
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
44
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
35
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
35
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
44
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
44
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
238
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
238
01:26Oral Drug Delivery Systems: Continuous-Release Systems
58
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
58
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
35
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
35